(Total Views: 587)
Posted On: 07/15/2020 1:31:47 PM
Post# of 154133
On a somewhat parallel note, Covid trial data is coming regardless of the progress of the HIV BLA and any FDA conspiracy or Cytodyn/Amarex malfeasance.
The long term prospects and myriad of likely clinical applications remain unchanged, IMO.
Whether leronlimab is authorized under EUA or an unlikely approval will be mostly immaterial to stock price and Covid patients needing it.
If trials meet endpoints with significance and no EUA, you can sign me up for the march on Washington.
The long term prospects and myriad of likely clinical applications remain unchanged, IMO.
Whether leronlimab is authorized under EUA or an unlikely approval will be mostly immaterial to stock price and Covid patients needing it.
If trials meet endpoints with significance and no EUA, you can sign me up for the march on Washington.
(2)
(1)
